Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/39610
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_DepressionAnxietyPatients.pdf682,68 kBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorTauil, Carlos Bernardo-
dc.contributor.authorLima, Amanda D. da Rocha-
dc.contributor.authorFerrari, Breno B.-
dc.contributor.authorSilva, Veronica A. G. da-
dc.contributor.authorMoraes, Adriel S.-
dc.contributor.authorSilva, Flavia M. da-
dc.contributor.authorSilva, Cesar A. Melo-
dc.contributor.authorFarias, Alessandro S.-
dc.contributor.authorBrandão, Carlos O.-
dc.contributor.authorSantos, Leonilda M. B. dos-
dc.contributor.authorSantos Neto, Leopoldo Luiz dos-
dc.date.accessioned2020-11-05T16:38:04Z-
dc.date.available2020-11-05T16:38:04Z-
dc.date.issued2020-10-23-
dc.identifier.citationTAUIL, Carlos B. et al. Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines. Brain, Behavior, & Immunity - Health, v. 9, 100162, dez 2020. DOI: https://doi.org/10.1016/j.bbih.2020.100162. Disponível em: https://www.sciencedirect.com/science/article/pii/S2666354620301277?via%3Dihub. Acesso em: 05 nov. 2020.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/39610-
dc.language.isoInglêspt_BR
dc.publisherElsevier Inc.pt_BR
dc.rightsAcesso Abertopt_BR
dc.titleDepression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod : role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokinespt_BR
dc.typeArtigopt_BR
dc.subject.keywordDepressão mentalpt_BR
dc.subject.keywordAnsiedadept_BR
dc.subject.keywordInflamaçãopt_BR
dc.subject.keywordEsclerose múltiplapt_BR
dc.subject.keywordIndoleamina 2,3-dioxigenasept_BR
dc.subject.keywordCitocinaspt_BR
dc.rights.license© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.bbih.2020.100162pt_BR
dc.description.abstract1Depression/anxiety (D/A) occurs in up to 50% of multiple sclerosis (MS) patients. Proinflammatory cytokines induce classical symptoms of depression. Activation of the inflammatory response also triggers production of indoleamine 2,3-dioxygenase (IDO), which catabolizes tryptophan, the amino acid precursor of serotonin and melatonin. It has been suggested that IDO is the link between the immune and serotonergic systems. This study aimed to quantify the levels of IDO and pro-inflammatory and anti-inflammatory cytokines in patients with MS and depression, according to treatment with interferon-beta (IFN-β) or fingolimod. The study inclusion criteria were age 18–60 years and a clinical and radiological diagnosis of MS. One hundred and thirtytwo patients diagnosed by McDonald’s criteria and followed up at Brasília District Hospital, Brazil, with relapsingremitting MS were identified as potential study participants. Thirty-five of these patients were identified to be receiving treatment with fingolimod or IFN-β and to have a diagnosis of D/A. IDO and pro-inflammatory and antiinflammatory cytokine levels were compared between these 35 patients and 18 healthy controls. The level of IL10 (an anti-inflammatory cytokine) was lower in both the fingolimod-treated (P < 0.001) and IFN-β-treated (P < 0.01) patient groups than in the control group. IFN-β-treated patients showed increased IDO expression and decreased inflammatory cytokine levels. In contrast, fingolimod-treated patients showed significantly decreased expression of IDO and significantly increased levels of proinflammatory cytokines produced by innate immune cells, including tumor necrosis factor-alpha and interleukin-6. The agents used to treat MS maintain symptoms of D/A in patients with MS via different mechanisms.pt_BR
dc.description.unidadeFaculdade de Medicina (FMD)-
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.